Skip to main content

Articles

Page 59 of 59

  1. Acute hyperglycaemia is an independent cardiovascular risk factor in Type 2 diabetes which may be mediated through increased oxidative damage to plasma low density lipoprotein, and in vitro, high glucose conce...

    Authors: Mike Sampson, Isabel Davies, Jelena Gavrilovic, Brendan Sussams, Jackie Brown, Sian Astley and David A Hughes
    Citation: Cardiovascular Diabetology 2004 3:7
  2. Arterial proteoglycans are implicated in the pathogenesis of atherosclerosis by their ability to trap plasma lipoproteins in the arterial wall and by their influence on cellular migration, adhesion and prolife...

    Authors: Iris J Edwards, Janice D Wagner, Catherine A Vogl-Willis, Kenneth N Litwak and William T Cefalu
    Citation: Cardiovascular Diabetology 2004 3:6
  3. Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its com...

    Authors: Philippe Woods, Carmen Paquette, Julie Martin, Jean-Gaston Dumesnil, Picard Marceau, Simon Marceau, Simon Biron, Frédéric Hould, Odette Lescelleur, Stéphane Lebel and Paul Poirier
    Citation: Cardiovascular Diabetology 2004 3:5
  4. Type 2 diabetes mellitus (DM-2) is one of the most prevalent chronic diseases of the aged and contributes to a significant amount of cardiovascular disease morbidity and mortality. Exercise training may be ben...

    Authors: Jonathan McGavock, Sandra Mandic, Richard Lewanczuk, Matthew Koller, Isabelle Vonder Muhll, Arthur Quinney, Dylan Taylor, Robert Welsh and Mark Haykowsky
    Citation: Cardiovascular Diabetology 2004 3:3
  5. Microalbuminuria and subsequent progression to proteinuria and nephropathy is associated with increased oxidative stress, increased inflammatory cytokines and increased cardiovascular (CVD) risk. The common fu...

    Authors: Jeffrey W Stephens, Steven J Hurel, Jayshree Acharya and Steve E Humphries
    Citation: Cardiovascular Diabetology 2004 3:2
  6. Vascularization is an exciting and complex mechanism involving angiogenesis and arteriogenesis. The metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) are associated with multiple metabolic toxicities...

    Authors: Melvin R Hayden and Suresh C Tyagi
    Citation: Cardiovascular Diabetology 2004 3:1
  7. Impaired fibrinolysis is found in impaired glucose tolerance and type 2 diabetes, associated with components of the metabolic syndrome. There are no data concerning fibrinolysis in subjects with normal glucose...

    Authors: Mats CE Eliasson, Jan-Håkan Jansson, Bernt Lindahl and Birgitta Stegmayr
    Citation: Cardiovascular Diabetology 2003 2:19
  8. Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with incre...

    Authors: Ariel Roguin, Samy Nitecki, Irit Rubinstein, Eviatar Nevo, Aaron Avivi, Nina S Levy, Zaid A Abassi, Edmond Sabo, Orit Lache, Meira Frank, Aaron Hoffman and Andrew P Levy
    Citation: Cardiovascular Diabetology 2003 2:18
  9. Diabetic dyslipoproteinemia is characterized by hypertriglyceridemia, low HDL-cholesterol and often elevated LDL-cholesterol and is a strong risk factor for atherosclerosis. Adhesion molecule levels are elevat...

    Authors: Klaus Empen, Robert JA Frost, H Christian Geiss, Carsten Otto and Klaus G Parhofer
    Citation: Cardiovascular Diabetology 2003 2:17
  10. Patients with diabetic cardiomyopathy have an impaired myocardial glucose handling and distal distribution of coronary atherosclerosis. Trimetazidine, an anti-ischemic metabolic agent, improves myocardial gluc...

    Authors: Giuseppe MC Rosano, Cristiana Vitale, Barbara Sposato, Giuseppe Mercuro and Massimo Fini
    Citation: Cardiovascular Diabetology 2003 2:16
  11. An insertion/deletion polymorphism in the α2B-adrenoceptor (AR) has been associated with the risk for acute myocardial infarction (AMI) and sudden cardiac death. In this study we tested whether this polymorphism ...

    Authors: Amir Snapir, Mika Scheinin, Leif C Groop and Marju Orho-Melander
    Citation: Cardiovascular Diabetology 2003 2:15
  12. Left ventricular hypertrophy (LVH) is a powerful independent risk factor for cardiovascular morbidity and mortality among hypertensive patients. Data regarding relationships between diabetes and LVH are contro...

    Authors: Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro and Joseph Shemesh
    Citation: Cardiovascular Diabetology 2003 2:14
  13. Even mild hyperglycemia is associated with future acute and chronic complications. Nevertheless, many cases of diabetes in the community go unrecognized. The aim of the study was to determine if national elect...

    Authors: Shlomo Vinker, Yaacov Fogelman, Asher Elhayany, Sasson Nakar and Ernesto Kahan
    Citation: Cardiovascular Diabetology 2003 2:13
  14. More than seventeen million Americans are afflicted with diabetes and these people have four times the rate of coronary heart disease (CHD) as non-diabetics. Furthermore, diabetic women have a 3.8 fold greater...

    Authors: Hillary A Tuttle, Grace Davis-Gorman, Steven Goldman, Jack G Copeland and Paul F McDonagh
    Citation: Cardiovascular Diabetology 2003 2:12
  15. The impressive correlation between cardiovascular disease and glucose metabolism alterations has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Inflammation is eme...

    Authors: Enrique Z Fisman, Michael Motro and Alexander Tenenbaum
    Citation: Cardiovascular Diabetology 2003 2:11
  16. Recently a new automatic device that measures brachial-ankle pulse wave velocity using an oscillometric method has been developed. However, the practical significance of brachial-ankle pulse wave velocity meas...

    Authors: Osamu Ogawa, Tomio Onuma, Sayaka Kubo, Naomi Mitsuhashi, Chie Muramatsu and Ryuzo Kawamori
    Citation: Cardiovascular Diabetology 2003 2:10
  17. A C825T polymorphism was recently identified in the gene encoding the β3 subunit of heterotrimeric G-proteins (GNB3). The T-allele is significantly associated with essential hypertension and obesity. In order to ...

    Authors: Jens Nürnberger, Sandra Dammer, Thomas Philipp, Rene R Wenzel and Rafael F Schäfers
    Citation: Cardiovascular Diabetology 2003 2:7
  18. Using the streptozotocin-induced diabetic rat model, we have recently showed that the expression and function of β1-adrenoreceptor were decreased in the diabetic rat heart. However, the effect of diabetes on expr...

    Authors: U Deniz Dinçer, Şahika Güner, Aydin Tay, Ebru Arioğlu, Atilay Taşdelen, Sait Aşlamaci and Keshore R Bidasee
    Citation: Cardiovascular Diabetology 2003 2:6
  19. Interleukin 8 (IL-8) is a cytokine with atherogenic properties. In vitro studies revealed that it is produced and secreted by human adipocytes. We recently reported that plasma IL-8 is increased in obese subje...

    Authors: Marek Straczkowski, Irina Kowalska, Agnieszka Nikolajuk, Stella Dzienis-Straczkowska, Malgorzata Szelachowska and Ida Kinalska
    Citation: Cardiovascular Diabetology 2003 2:5
  20. The metabolic syndrome is a highly prevalent clinical entity. The recent Adult Treatment Panel (ATP III) guidelines have called specific attention to the importance of targeting the cardiovascular risk factors...

    Authors: Alexander Tenenbaum, Enrique Z Fisman and Michael Motro
    Citation: Cardiovascular Diabetology 2003 2:4
  21. Coronary plaque rupture may result from localised over expression of matrix metalloproteinases (MMPs) within the plaque by infiltrating monocyte – macrophages. As MMP expression can be promoted by the modified...

    Authors: Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes and Mike J Sampson
    Citation: Cardiovascular Diabetology 2003 2:3
  22. Cardiovascular disease accounts for at least 85 percent of deaths for those patients with type 2 diabetes mellitus (T2DM). Additionally, 75 percent of these deaths are due to ischemic heart disease.

    Authors: Melvin R Hayden and Suresh C Tyagi
    Citation: Cardiovascular Diabetology 2003 2:2
  23. Our aim is to summarize and discuss the recent literature linking diabetes mellitus with heart failure, and to address the issue of the optimal treatment for diabetic patients with heart failure.

    Authors: Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire and Pascal de Groote
    Citation: Cardiovascular Diabetology 2003 2:1
  24. There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolip...

    Authors: Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone and Pietro Fratino
    Citation: Cardiovascular Diabetology 2002 1:5
  25. The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early...

    Authors: Radka Lichnovská, Simona Gwozdziewiczová and Jirí Hrebícek
    Citation: Cardiovascular Diabetology 2002 1:4
  26. Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple met...

    Authors: Melvin R Hayden and Suresh C Tyagi
    Citation: Cardiovascular Diabetology 2002 1:3
  27. The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed ...

    Authors: Enrique Z Fisman, Alexander Tenenbaum and Michael Motro
    Citation: Cardiovascular Diabetology 2002 1:2

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    55 days submission to accept (Median)

    2022 Usage 
    2,116,496 downloads
    14,109 Altmetric mentions